The report shows strong growth in Asian markets, with India at 8.8% CAGR, followed by China (8.7%) and South Korea (8.6%).

Chinese pharma giant Shanghai Pharmaceuticals is in talks with major Indian pharmaceutical companies for greater access to ...

API prices have been under pressure over the past few quarters due to weak demand and competition from China in export ...

Y-o-Y Growth and Strong Performance in 2024 The Small Molecule API market is anticipated to exhibit a Y-o-Y growth of 4.6% in ...

Report Ocean has published a new report on the Saudi Arabia Active Pharmaceutical Ingredients (API) Market, delivering an extensive analysis of key factors such as market restraints, drivers, and ...

India is seeking to bolster local production and cut its import dependence by half for critical pharmaceutical ingredients, ...

The U.S. leads the global plant-based API market, growing at a 4.2% CAGR, powered by biotech and agri-tech advances. With CRISPR and synthetic biology, the U.S. rapidly scales plant-derived APIs for ...

DHAKA, Nov 10, 2024 (BSS) - Dhaka Chamber of Commerce and Industry (DCCI) President Ashraf Ahmed today invited Argentine ...

( MENAFN - KNN India) New Delhi, Nov 14 (KNN) India is taking a significant step to reduce its reliance on Pharmaceutical ...

The company behind ChatGPT didn’t set out to tackle health care. But despite ongoing concerns about its technology’s tendency ...

Akums Drugs and Pharmaceuticals has witnessed its net profit for the second quarter of the current fiscal year doubling to Rs. 66.65 crore from Rs. 32.69 crore registered during the same quarter last ...